Results 171 to 180 of about 26,857 (227)

Treatment-Emergent Bictegravir Resistance in a Treatment-Naive Individual With HIV Infection: A Case Report. [PDF]

Cureus
Dubson I, Gaur A, Jose J, Andrews C, Gaballa A, McFarlane SI.   +5 more
europepmc   +1 more source

Therapeutic Opportunities in Infectious Diseases: Highlights from the Society of Medicines Research Symposium, held on March 14th 2013 at the National Heart & Lung Institute, London, UK

, 2013
Collingwood, S P, Pryde, D C, Anderson, RJ, Collingwood, SP, Pryde, DC, Anderson, Rosaleen, Alderton, W K, Alderton, WK   +7 more
core  

Time to Antiretroviral Therapy Initiation After HIV Diagnosis in the Integrase Strand Transfer Inhibitor Era - Nanjing City, Jiangsu Province, China, 2021-2024. [PDF]

China CDC Wkly
Ma C, Yang J, Liu A, Qian Z, Liu Z, Ge Y, Xu Y, Zhu Z, Wei H, Peng Z, Yin G, Hu Z.   +11 more
europepmc   +1 more source

Novel integrase mutations linked to genotypic DTG resistance in African non-B HIV-1 strains: the DTG RESIST study. [PDF]

J Antimicrob Chemother
Han N, Loosli T, Sauermann M, Çelikağ İ, Anderegg N, Baye BC, Bolton Moore C, Buzaalirwa L, Byakwaga H, Chimbetete C, Ebasone PV, Goodrich S, Huwa J, Kasozi C, Mafoua A, Massamba AC, Messou E, Minga A, Murenzi G, Muula G, Muyindike W, Naidoo SJ, Nsonde DM, Poda AG, Ramdé R, Semeere A, Singh L, Günthard HF, Egger M, Giandhari J, Lessells R, Kouyos RD.   +31 more
europepmc   +1 more source

Block-and-Lock Approaches for HIV Cure: Mechanistic Insights, Challenges, and Emerging Role of CPSF6. [PDF]

Int J Mol Sci
Tolomeo M, Cascio A.
europepmc   +1 more source

Maintain, not obtain: rethinking HIV care in sub-Saharan Africa in the era of dolutegravir. [PDF]

Front Public Health
Perno CF, Orlando S, Majid NA, Sangare H, Luanga R, Roccucci M, Silaghi LA, Sidumo Z, Brambilla D, Ceffa S, Guidotti G, Ciccacci F.   +11 more
europepmc   +1 more source

Effect of naturally occurring polymorphisms on HIV-1 integrase structure and dolutegravir binding in subtypes A1 and D

Ssekagiri A, Ssemwanga D, Bbosa N, Kateete DP, Jjingo D.   +4 more
europepmc   +1 more source